Medicina y Especialidades Médicas
Departamento
University of Naples Federico II
Nápoles, Italia
2026
- Clinical and laboratory markers to distinguish VEXAS from Schnitzler's syndrome: data from the AIDA network registries
Frontiers in Medicine, Vol. 12
- Indexed Aortic Valve Calcium Volume by Computed Tomography Angiography in Patients With Aortic Stenosis: Results of an International Multicenter Cohort Study
JACC: Cardiovascular Imaging, Vol. 19, Núm. 2, pp. 210-221
- Prognostic significance of concomitant valvular disease in moderate aortic regurgitation
European Heart Journal Cardiovascular Imaging, Vol. 27, Núm. 5, pp. 1059-1067
- Recurrent fever and association with severe organ involvement, mortality and treatment outcomes in VEXAS syndrome: data from the AIDA Network
Frontiers in Immunology, Vol. 17
- The incidence of early recurrent venous thromboembolism: a systematic review and meta-analysis
Research and Practice in Thrombosis and Haemostasis, Vol. 10, Núm. 1
- VEXAS syndrome and cancer: Insights about a possible “Tip of the Iceberg”. Ambidirectional data from the international AIDA network registries
Seminars in Arthritis and Rheumatism, Vol. 77
2025
- Baseline Hemoglobin Values and Clinical Outcomes in Acute Venous Thromboembolism: Insights From the RIETE Registry
American Journal of Hematology
- Efficacy and safety of conventional disease-modifying antirheumatic drugs in VEXAS syndrome: real-world data from the international AIDA network
Frontiers in Pharmacology, Vol. 16
- Expert consensus for prevention, diagnosis and management of persistent chemotherapy-induced alopecia
Journal of the European Academy of Dermatology and Venereology, Vol. 39, Núm. 12, pp. 2039-2046
- Safety of ceftobiprole in patients with impaired renal, hepatic or immune function: A multinational retrospective hospital chart review (RETRACE study)
International Journal of Antimicrobial Agents, Vol. 65, Núm. 4
- State of the art management practices for liver glycogen storage disorders: Results from an international survey among metabolic centres
Molecular Genetics and Metabolism, Vol. 145, Núm. 3
2024
- Epidemiology, pathophysiology, diagnosis and management of chronic right-sided heart failure and tricuspid regurgitation. A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC
European Journal of Heart Failure, Vol. 26, Núm. 1, pp. 18-33
2023
- Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)
Nature
- Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)
Nature
- European Society of Cardiology quality indicators for the prevention and management of cancer therapy-related cardiovascular toxicity in cancer treatment
European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 9, Núm. 1, pp. 1-7
2022
- European survey on valvular heart disease clinical experience from the European Society of Cardiology council on valvular heart disease
European Heart Journal Open, Vol. 2, Núm. 5
2021
- Mapping the human genetic architecture of COVID-19
Nature, Vol. 600, Núm. 7889, pp. 472-477
2020
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk
European Heart Journal, Vol. 41, Núm. 1, pp. 111-188
- Imaging in patients with suspected acute heart failure: timeline approach position statement on behalf of the Heart Failure Association of the European Society of Cardiology
European Journal of Heart Failure, Vol. 22, Núm. 2, pp. 181-195
- Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC)
European Journal of Heart Failure, Vol. 22, Núm. 9, pp. 1504-1524
